The Pros And Cons Of Epipens

Superior Essays
According to the New York Times, the cost of EpiPens has risen from $57 in 2007 to over $600 for a pack of two in 2016. EpiPens are vital to the safety of those who have life-threatening allergies to things such as bees or peanuts and it is recommended that their EpiPens be replaced every year. People with a need for EpiPens must find a way to pay the $600 for them when they expire each year. The dramatic increase in price is due to the monopoly that EpiPen has over the industry of epinephrine. After a company creates a unique drug, it is issued a patent that prevents any other sellers from entering the industry, giving the single company the power to charge whatever price that they see fit. Patents give pharmaceutical companies monopolies …show more content…
These obscene prices have sparked a massive protest from people who rely on this medicinal product to survive. The increase in price has made it harder for many to afford so many have demanded a decrease in price. However, the company argues that since they made the product, they should be allowed to sell their product for whatever price they decide on.

Pros of Patenting (Megan): Medical drug prices are affected greatly by the existence of patents. Many economists support the phenomenon of patenting drugs due to the benefits that patents have in the field of medicine and the drawbacks that can exist when they are not used. For example, patents are crucial to the research and development of new drugs. For a company to get a drug to the market, they must go through a very challenging, time-consuming, and tedious process of attempting to discover and produce a new drug. This task includes numerous failures and even if a new drug is discovered, it is not always approved for distribution in the market. It often takes up to twenty years to complete
…show more content…
Economists from this school of thought believe that drug patenting is unfair to consumers as patenting creates a monopoly. Big corporations claim intellectual property of the products through a patent and are given the authority to produce this drug. “A drug company that holds patents on a medicine has the right to prevent others from manufacturing it “ (“The Impact of Patents on Access to Medicines”). Therefore, pharmaceutical companies have the legal right to sue other companies that attempt to produce similar drugs. Thus the company holding the patent becomes the sole producer of that patented drug. As a result, there are no other company that can produce the drug and consequently, no close substitutes of such a drug. Companies now have the authority to “charge an artificially high price”(“The Impact of Patents on Access to Medicines”). With no competition or restrictions, there is nothing holding back drug companies. If a consumer wants to purchase this patented drug, the consumer must buy the drug from that specific company at the set price. Furthermore, “patent protected drugs are often essential for people’s health or even their lives. Allowing a drug company to have a monopoly where it can charge whatever it can force the individual, or more typically the insurer or the government, to pay makes little sense” (Baker). Medical pharmaceuticals are perfectly inelastic, meaning that at any price,

Related Documents

  • Improved Essays

    An example of this is the recent price increase of Daraprim that was priced at $750 by Turing Pharmaceuticals, simply because they could. (Pollack)…

    • 674 Words
    • 3 Pages
    Improved Essays
  • Great Essays

    Well the reason for that is they need higher drug prices in order for them to have enough money for research. In some hospitals “ we often must pay deep money for medical research”. They make us pay so much more to help them find the research they need. They deduct us more for research to save others lives. Which you could look at that being a win win situation you get the drug which makes you feel better, and the money you spend on getting that drug can benefit another person because of the research they now can do. They way I look at it is if we didn 't we spend so much money on advertising on drugs then maybe we would be able to lessen the cost of drugs.We used last year 650 million dollars on drugs. Another source even said that prescription drugs are going to be raised 13.6%. The reason is because they lack “ true universal health plan” so because of that they think they can do whatever they want with the money.They aren 't playing with there money smart, and not seeing that advertising drugs if stopped can leave us with more money for much more beneficial things. Last year we spent “ $3.1 billion on advertising prescription drugs directly to consumers in 2012”. So why is it that we are spending more on advertising on drugs then the actually drugs itself? We shouldn 't be spending that much of our money on advertising when they could be spending our money on medical journals and involve…

    • 2270 Words
    • 9 Pages
    Great Essays
  • Improved Essays

    The main aspect was the lack of competition that makes pharmaceutical companies easily to set up the price and it makes other companies to not compete against each other. These high prices are the result of the built-lack of competition because the U.S. and other governments give pharmaceuticals to have the good amount of time to develop a new drug (Taylor, 2015). The competition in the drug market nonexistent due to reasons that different pharmaceutical companies focus on a specific drug that other companies are not doing. To the pharmaceuticals, it all about making the profit. Without another company competing, that specific drug has more value to the consumer because it 's a necessity and they will be paying for the expensive drug. Other than competition, the articles state about having more bargaining power with the pharmaceutical companies. The United States health care system, allows insurers like Medicare to bargain to set enrollees’ drug prices could serve as something of a stand-in (Taylor, 2015). A way to pay for low-cost drugs, insurers can negotiate with the pharmaceutical on getting discounts where they can bring down the prices or they can even question the value of their drugs and compare to similar drugs. But in order to have more bargaining power, there need to be more drugs available to treat the particular conditions (Taylor, 2015). However, if the drug is really effective and it’s the only pharmaceutical that has the drug, they are unlikely to lower price and could even put a heavier cost. These two methods in the articles described a way to change the regulation of how pharmaceuticals adjust their…

    • 1525 Words
    • 7 Pages
    Improved Essays
  • Superior Essays

    The rise in prices of prescription drugs is an issue that does not seem to be going away…

    • 2472 Words
    • 10 Pages
    Superior Essays
  • Superior Essays

    Ethical Ethics Of Epipen

    • 1698 Words
    • 7 Pages

    The reason behind it all boils down to intellectual property rights. Meanings they own the rights to create such medicine and no one can either make it quite the same or no one else can make it at all; depends on the patents at hand. For example, with the Epipen; Mylan owns ninety percent of the epinephrine industry which means they control mostly what happens with epinephrine and what not. They 've created a monopoly because they are the deciding factor to drugs like the EpiPen. It 's kind of weird that some competitors to Epipen had recalls or issues after they were released. If you ask me that 's kind of suspicious. If we look deeper into Mylan having these rights to being the main creators of epinephrine we can see why they have created such a distant price. They can say that they are the best and no one can compete blah blah blah. But in the end, the same product they charged two sum odd hundred dollars for is now a ridiculous six hundred plus dollars. This raises a red flag to a deontologist but to the government, it is completely legal and allowed. Makes you wonder if the government cares at all or if they use it as population control knowing not everybody can afford some of the increases. To a deontologist, we would say that it is wrong not only because what is the justification to the price hike…profit? Who benefits from that just the creator…

    • 1698 Words
    • 7 Pages
    Superior Essays
  • Improved Essays

    However, the real problem recently is that they are jacking the prices, or doing multiple price increase multiple time a year. Johnson & Johnson raised its price on several top-selling drugs, such as Imbruvica for treating leukemia, Invokana for treating diabetes, Xarelto for blood anti-clotting. Other big companies including Amgen, Gilead, Celgene also hike their drugs list prices (Thomas Katie). List prices for drugs increases more than 12% in 2015, more than the increase of past 5 years combined. Many believe the drug cost increase is caused by the non-existent drug price regulations in the US to protect consumers from price gauging by drug companies. In the case like the drug Daraprim,…

    • 1043 Words
    • 5 Pages
    Improved Essays
  • Improved Essays

    Bayh-Dole Act 1970

    • 796 Words
    • 4 Pages

    48 However, the Bayh-Dole Act has resulted in direct institutional ownership of parts of the intellectual property that protects many new drugs.49 To justify granting these private patent rights for government-sponsored inventions, one cannot use the typical innovation incentive of patents, because academic researchers have been innovating long before the Bayh-Dole Act and are primarily motivated by a desire for prestige.so Instead, Bayh-Dole patents typically are justified under commercialization theory-the idea that companies need exclusive patent rights to bring an invention to market."' Commercialization theory is not appropriate for many industries, but exclusive rights may be needed in the pharmaceutical industry because of the high cost of FDA approval and low cost of…

    • 796 Words
    • 4 Pages
    Improved Essays
  • Great Essays

    The health care industry has no regulations. Which means things like prescription medicine can have extreme price changes over night. Which has happened in recent years. The in article by Tom McKay called “Here 's How Much More the US Spends on Medicine than Everyone Else, in 6 Charts” he mentions how “The world has been repulsed by Martin Shkreli, the Turing Pharmaceuticals head and former hedge fund manager who bought the rights to the anti-protozoal drug Daraprim and raised the price by 5,500% overnight.” (McKay) Then Martin Shkreli claimed that the price increase was to help with the cost of researching. Which is absurd. Could you image if from one day to the next the medicine that you cannot live without had a price increase of 5,500 percent. That should not be allowed to happen to…

    • 1676 Words
    • 7 Pages
    Great Essays
  • Improved Essays

    Over Medicated Essay

    • 512 Words
    • 3 Pages

    Last year, pharmacist filled 4,468,929,929 prescriptions in the United States that is an 85 percent increase from just twenty years earlier (Carr, Rabkin, and Skinner 38). With these kinds of numbers, it must be obvious the process to develop drugs in America is working like a well-oiled machine, or is it? Prescription drug companies, the Food and Drug Administration (FDA) and independent research companies including universities all work together to develop improved medications. Each one has an unbiased, independent role to play in the process, however, over the years the unbiased independent part has become blurred. The Federal Government has made changes to regulations and health care policies, consequently, the prescription drug company’s…

    • 512 Words
    • 3 Pages
    Improved Essays
  • Improved Essays

    Obama Care Wrong

    • 1374 Words
    • 6 Pages

    The same sentiments should also apply in the case of pharmaceutical price gouging. Indeed, Obamacare should look into reducing drug prices to ensure its survival in the American health care system (Pipes, 29). According to Generic Drug Price Gouging Theory, drug prices in the domestic markets are skyrocketing compared to international markets. For instances, drugs prices in the American market rose 11% higher back in 2011 compared to Canadian, France and Switzerland market, mainly due to American greed and the supply and demand. Resultantly, millions of Americans go without drugs every day due to unaffordable drug prices (Marcovici,…

    • 1374 Words
    • 6 Pages
    Improved Essays
  • Superior Essays

    I believe that the government should regulate the sales of epipens because the “Mylan” company has a monopoly on them and is unfairly controlling the price. The price of epipens has been raised over 400% in the past few years because Mylan’s one competitor had a recall due to possible errors in drug dosage. The drug used in epipens, epinephrine, is inexpensive and each epipen carries only a dollars worth. The injector itself is bought by Mylan from a manufacturer for only $34.50 per pen! This is a very unfair raise in price and something needs to be done. European governments have lowered the cost to around $70 per pen, so why won’t ours? *1…

    • 1585 Words
    • 7 Pages
    Superior Essays
  • Great Essays

    Epipen Case Study

    • 1781 Words
    • 8 Pages

    In turn, pharmaceutical prices have also increased, as seen with the price of the EpiPen. Furthermore, a study done by the Congressional Budget Office emphasizes the lack of the output of new drugs in recent years, which highlights the need for an increase in further research and development (“Research and Development,” 2006). This being said, society’s need for new, innovative pharmaceuticals is only possible through further research and development, which requires sufficient funding from pharmaceutical companies that is attained through drug…

    • 1781 Words
    • 8 Pages
    Great Essays
  • Great Essays

    The Medicines Patent Pool

    • 1428 Words
    • 6 Pages

    If patents on their drugs are continually allowed renewal, no competitive manufacturer with the intent of creating a more affordable product for consumers will ever enter the market. In the age of ever-present fear of being sued, the aforementioned is likely palpable. Bio-pharmaceutical giant, Sanofi, is currently in the process of updating a popular version the drug Lantus, which comes off of patent later this year. This product may be offered at a different level of concentration, which experts claim could reduce the cost to patients by 30 to 40%. However, the validity of these claims remains to be seen. Buying insulin isn’t like purchasing expensive denim. When given the choice to purchase a pair of $20 jeans from Walmart or a pair of $350 jeans from a specialty boutique, one could argue the expensive jeans are made from superior material, by hand, and will probably last longer. Whereas, the $20 may last awhile, but will likely fail sooner and be less comfortable. With insulin, there is only one material. The one with the name brand label is likely going to be no better than the hypothetical start-up companies’; both will work the same, and save lives. Stripping the ability to obtain patents on medical products that are essentially identical will ultimately bring more equality to the…

    • 1428 Words
    • 6 Pages
    Great Essays
  • Improved Essays

    In this step, most of the economic forces come into play; namely pricing and competition. In terms of pricing, does the company price its drugs above its production costs or does it research the price that the market would bear? (Hooper, 2008). The answer is never that easy. Companies that wish to maximise profit will set high prices for consumers that are willing to pay; however, the same drug in a poor country might be priced lower (Hooper, 2008). The drug Crixivan, for example, is priced differently in Africa than it is in the US. Merck, the company that manufactures Crixivan is able to charge over six thousand dollars for a year’s supply in the US; however, the same drug costs six hundred dollars in Africa for a year’s supply (Hooper, 2008). The other economic force is competition. Although brand-name drug manufacturers do compete between each other based on price, another form of competition, which will be discussed later, is the rise of the generics industry. The rise of the generics industry can be contributed to government policy whereby governments allow generic-drug makers to conduct research on patented drugs prior to the expiry of the patent. This presents consumers with a lower cost equivalent of the brand name drug. The ascent of generic-drug manufacturers, could be argued, is attributed to the public interest theory of…

    • 984 Words
    • 4 Pages
    Improved Essays
  • Improved Essays

    Ratio Of Patient Care

    • 1165 Words
    • 5 Pages

    Now that is usually for people with medical insurance of some kind, take away that insurance and then a person realizes how much these pills actually cost. A Lancet article even went on to say, “...as many as one in four who can’t afford the high prices to go without their medicine…” (Jaffe 1). This information was brought a upon by a Kaiser Family Foundation Survey and really shows that people are truly affected by these high costs. According to recent studies done, the US has the highest costs for pharmaceuticals on the planet. This is mostly due to the high amount of FDA (Food and Drug Administration) restrictions and laws they have put in place. Only about 1% of drugs on trial actually make it to shelves. Some trials take about 5-20 years to complete and to pass the FDA steps and stages to ensuring it is a usable and sellable product that does not hurt the human population. Because of the time invested into the trials and how long it takes for the drug to actually be cleared, the amount of funding needed in order to keep the trials running is very extensive. Due to the time and amount of funds that are needed, pharmaceutical companies have a extremely high development cost for drugs. They do this because they have to make up for the money they already spent on the drug to get it approved, and also to attempt to make a…

    • 1165 Words
    • 5 Pages
    Improved Essays